Zurück
Fighting Chronic Problems: Savient’s CEO Explains
www.pharmalot.com/2012/10/...c-problems-savients-ceo-explains/
Ein Auszug (-das passt ja zur News vom Freitag!-):
...Pharmalot: Any other milestones coming up?
Ferrari: We’re expecting to hear back from the CHMP in Europe over the next couple of weeks on an opinion. That will be a milestone...
Wird wohl der nächste Schritt:
...Pharmalot: And how is the partnership hunt going?
Ferrari: We’re looking for a partner in Europe and the rest of the world. There are a number of companies that have expressed interest and we’re in active discussions. We don’t want to go it alone in Europe. It would have cost us $30 million or more to go forward in Europe at a time when we were battling on a lot of fronts. But right now, we have two years’ worth of cash. And we’re not under any pressure to raise any more. But we think any partnership ex-US will bring us some good revenues, including what we believe will bring upfront payments and royalties. Right now I think we’re in a pretty good spot...
www.pharmalot.com/2012/10/...c-problems-savients-ceo-explains/
Ein Auszug (-das passt ja zur News vom Freitag!-):
...Pharmalot: Any other milestones coming up?
Ferrari: We’re expecting to hear back from the CHMP in Europe over the next couple of weeks on an opinion. That will be a milestone...
Wird wohl der nächste Schritt:
...Pharmalot: And how is the partnership hunt going?
Ferrari: We’re looking for a partner in Europe and the rest of the world. There are a number of companies that have expressed interest and we’re in active discussions. We don’t want to go it alone in Europe. It would have cost us $30 million or more to go forward in Europe at a time when we were battling on a lot of fronts. But right now, we have two years’ worth of cash. And we’re not under any pressure to raise any more. But we think any partnership ex-US will bring us some good revenues, including what we believe will bring upfront payments and royalties. Right now I think we’re in a pretty good spot...
